Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 4859
Journal of Addiction Research & Therapy received 4859 citations as per Google Scholar report
Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
- CAS Source Index (CASSI)
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- SafetyLit
- China National Knowledge Infrastructure (CNKI)
- Electronic Journals Library
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- SWB online catalog
- Virtual Library of Biology (vifabio)
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Modulation of drug-seeking by hypothalamic peptide systems: Implications for developing pharmacological treatments to treat drug relapse
International Conference and Exhibition on Addiction Research & Therapy
Christopher V Dayas
ScientificTracks Abstracts: J Addict Res Ther
Abstract
The relevance of ethical issues for an information provider in the field of drugs and drug addiction, as it is the case of the EMCDDA, to carry out its activities has been repeatedly pointed out. As such, several of its main partners, as the UNODC or the Council of Europe Pompidou Group, have developed in a recent past concrete initiatives aiming firstly to identify what are the most relevant ethical issues in the field of drug-related information and to establish afterwards ethical frameworks helping decisions-makers, scientists and practitioners to better develop their own activities in their respective fields of activities. These questions are essential to effectively carry out EMCDDA activities in the field of collection, evaluation, assessment and dissemination of drug information, both in the area of demand and demand reduction and in the one of supply and supply reduction. The EMCDDA amended mandate also requires an ethical basis to better inform its activities in a number of new fields. Among these, one may underline some possible future activities relating, for instance, with non substance based addictions. The main topics on which the drug related ethical debate has been focused till now are: Vaccination against drug dependence; Quasi-coerced treatment for drug users; Non voluntary drug testing; Medical research; and Epidemiological research. Within the future development of the EMCDDA activities, the list of topics which could be provisionally identified as having an ethical dimension is extremely vast. An in depth scientific basis on these issues seems then to be essentialBiography
Ignacio Vzquez Molin (Madrid, 1963) has a Law degree by the Universidad Complutense de Madrid, Spain and completed his Ph.D in Hispanic Philology at the age of 43 years at UNED, Madrid, Spain. He has been a European Union official since 1992. Currently, he is Principal Administrator, being in charge within the EMCDDA Directorate of Diplomatic Relations and Ethical Issues. He is also the EMCDDA Data Protection Officer. He also teaches comparative literature at the Instituto de Estudios Ibricos e Iberoamericanos, Universidade Nova de Lisboa, Portugal. He has published many articles on literature and history and several fiction books
